| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701977 | Journal of Thoracic Oncology | 2017 | 7 Pages |
Abstract
Efficacy was not improved in patients with nonsquamous NSCLC when cixutumumab was added to pemetrexed/cisplatin. Combination therapy was well tolerated and no new safety concerns were reported.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Silvia MD, PhD, Giorgio MD, PhD, Gilberto MD, PhD, Murat MD, Rubén MD, MSc, Karl-Matthias MD, Edurne MD, PhD, Lionel MD, Ruslan D. MD, PhD, Tuan S. PhD, Amelie MSc, Shande PhD, Siva Rama Prasad PhD, Jan MD, Martin MD, PhD,